Related references
Note: Only part of the references are listed.Abatacept Use Is Associated with Steroid Dose Reduction and Improvement in Fatigue and CD4-Dysregulation in CVID Patients with Interstitial Lung Disease
Caroline von Spee-Mayer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Autoimmune Lymphoproliferative Syndrome An Overview
Daniel R. Matson et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score
Victoria Katharina Tesch et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Clinical, Immunological, and Genetic Features in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) and IPEX-like Syndrome
Mahnaz Jamee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis
Nina K. Serwas et al.
NATURE COMMUNICATIONS (2019)
Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency
Ayca Kiykim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition
Peter Chei-way Pan et al.
CURRENT ONCOLOGY REPORTS (2019)
Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
Christian Klemann et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management
Uday N. Shivaj et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects
Charlotte Schwab et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient Patient
Ester M. van Leeuwen et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2018)
Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy
James Varley et al.
NEUROPHARMACOLOGY (2018)
Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T cells
Angela Deya-Martinez et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2018)
Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
Philipp Scheuerlein et al.
FRONTIERS IN IMMUNOLOGY (2018)
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
David Egg et al.
FRONTIERS IN IMMUNOLOGY (2018)
CTLA-4 haploinsufficiency in a patient with an autoimmune lymphoproliferative disorder
Zeynep Yesim Kucuk et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders
John R. Hurst et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Autoimmunity/inflammation in a monogenic primary immunodeficiency cohort
William Rae et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2017)
The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia
Donald M. Arnold et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination
Sudarshini Ramanathan et al.
AUTOIMMUNITY REVIEWS (2016)
Hematopoietic stem cell transplantation for CTLA4 deficiency
Mary A. Slatter et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4
Sangmoon Lee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies
Jolan E. Walter et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)
Lymphoproliferative disease and cancer among patients with common variable immunodeficiency
S. Gangemi et al.
LEUKEMIA RESEARCH (2015)
Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4
Sebastian Zeissig et al.
GUT (2015)
European consensus proposal for immunoglobulin therapies
W. A. Carrock Sewell et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Abatacept A New Treatment Option for Refractory Adult Autoimmune Enteropathy
Nitin K. Gupta et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations
Desiree Schubert et al.
NATURE MEDICINE (2014)
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
Hye Sun Kuehn et al.
SCIENCE (2014)
A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
Henrik Birgens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients
G. K. Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity
Gabriela Lopez-Herrera et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients
Delphine Gobert et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases
Marc Michel et al.
BLOOD (2009)
Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID)
J Wang et al.
JOURNAL OF AUTOIMMUNITY (2005)
Share Paper
